Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA Effects on Interpersonal Interaction
NCT05123716Phase 1Completed
- Sponsor
- University of Chicago
- Start
- Aug 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of midomafetamine in post-traumatic stress disorder (PTSD) (2 arms), sponsored by University of Chicago. Primary endpoints: Feelings of closeness and connection, Profile of Mood States and 1 more. Started Aug 2021; status: completed.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT05123716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05123716.